(Q39465532)

12 September 2017

1 reference

title

The pathogenesis of humoral hypercalcaemia of malignancy (English)

1 reference

12 September 2017

S H Ralston

1

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 December 1987

1 reference

12 September 2017

1 reference

12 September 2017

volume

2

1 reference

12 September 2017

issue

8573

1 reference

12 September 2017

page(s)

1443-1446

1 reference

The hypercalcemia of malignancy: pathogenesis and management

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991139-1

7 January 2021

Abnormal vitamin D metabolism in Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991139-1

7 January 2021

Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991139-1

7 January 2021

Hypercalcaemia and metastatic bone disease: is there a causal link?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991139-1

7 January 2021

Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991139-1

7 January 2021

Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991139-1

7 January 2021

Prostaglandins: stimulation of bone resorption in tissue culture

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991139-1

7 January 2021

Prostaglandins as Mediators of Hypercalcemia Associated with Certain Types of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991139-1

7 January 2021

Plasma prostaglandin E in patients with cancer with and without hypercalcemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991139-1

7 January 2021

Intravenous Infusion of Prostaglandin E2Raises Plasma Calcium Concentration in the Rat*

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991139-1

7 January 2021

EGF receptor antiserum inhibits bone resorbing activity produced by a rat Leydig cell tumor associated with the humoral hypercalcemia of malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991139-1

7 January 2021

Bone resorption and humoral hypercalcemia of malignancy: stimulation of bone resorption in vitro by tumor extracts is inhibited by prostaglandin synthesis inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991139-1

7 January 2021

Humoral hypercalcemia of malignancy. Release of a prostaglandin-stimulating bone-resorbing factor in vitro by human transitional-cell carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991139-1

7 January 2021

Actions of growth factors on plasma calcium. Epidermal growth factor and human transforming growth factor-alpha cause elevation of plasma calcium in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991139-1

7 January 2021

Identification of 1,24(R)-dihydroxyvitamin D3-like bone-resorbing lipid in a patient with cancer-associated hypercalcemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991139-1

7 January 2021

Absence of parathyroid hormone messenger RNA in nonparathyroid tumors associated with hypercalcemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991139-1

7 January 2021

Hypercalcaemia of malignancy: evidence for a nonparathyroid humoral agent with an effect on renal tubular handling of calcium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991139-1

7 January 2021

Comparison of intestinal calcium absorption and circulating 1,25-dihydroxyvitamin D levels in malignancy-associated hypercalcaemia and primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991139-1

7 January 2021

Circulating 1,25-dihydroxyvitamin D concentrations in patients with renal cell carcinoma-associated hypercalcemia are rarely suppressed

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991139-1

7 January 2021

Quantitative bone histomorphometry in humoral hypercalcemia of malignancy: uncoupling of bone cell activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991139-1

7 January 2021

Small intestinal function in malignant neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991139-1

7 January 2021

Human renal carcinoma cells produce hypercalcemia in the nude mouse and a novel protein recognized by parathyroid hormone receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991139-1

7 January 2021

Malignancy-Associated Hypercalcemia: Evaluation with a Cytochemical Bioassay for Parathyroid Hormone*

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991139-1

7 January 2021

Purification of peptides with parathyroid hormone-like bioactivity from human and rat malignancies associated with hypercalcemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991139-1

7 January 2021

A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991139-1

7 January 2021

Recent advances in parathyroid hormone research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991139-1

7 January 2021

Radioimmunoassay of parathyroid hormone in hypercalcemic patients with malignant disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991139-1

7 January 2021

Urinary and nephrogenous adenosine 3',5'-monophosphate in the hypercalcemia of malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991139-1

7 January 2021

A parathyroid hormone-like protein from cultured human keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991139-1

7 January 2021

Biochemical and histomorphometric characterization of a rat model for humoral hypercalcemia of malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991139-1

7 January 2021

Failure of parathyroid hormone antagonists to inhibit in vitro bone resorbing activity produced by two animal models of the humoral hypercalcemia of malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991139-1

7 January 2021

A parathyroid hormone inhibitor in vivo: design and biological evaluation of a hormone analog

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991139-1

7 January 2021

10.1016/S0140-6736(87)91139-1

Identifiers

DOI

1 reference

release_a32tmjgonra3tlzeuhaidqyive

12 September 2017

Fatcat ID

0 references

1 reference